A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 5932-27-4, Name is Ethyl 1H-pyrazole-3-carboxylate, molecular formula is C6H8N2O2. In an article, author is Amin, Sk. Abdul,once mentioned of 5932-27-4, COA of Formula: C6H8N2O2.
Exploring indole derivatives as myeloid cell leukaemia-1 (Mcl-1) inhibitors with multi-QSAR approach: a novel hope in anti-cancer drug discovery
In humans, the over-expression of Mcl-1 protein causes different cancers and it is also responsible for cancer resistance to different cytotoxic agents. Thus, discovery of potential inhibitors of Mcl-1 is very important and both the pharmaceutical industry and academia are looking at it in the quest for new anticancer drugs. In the present study, different molecular modelling techniques such as recursive partitioning, Bayesian classification, structural and physico-chemical interpretation analysis and pharmacophore mapping were employed in order to identify the crucial structural fingerprints important for the optimization of 143 indole derivatives as Mcl-1 inhibitors. These modelling studies emphasize that hydrophobic naphthyl rings, methyl-substituted 1H-pyrazole moiety, N(1)-tethered morpholinoethyl group, chloro substitutions at the 6th position of indole nucleusetc.are beneficial for Mcl-1 binding. Finally, statistically validated classical QSAR and machine learning-based models were also developed for screening and prediction of different indole derivatives as Mcl-1 inhibitors. The modelling analyses will help medicinal chemists to design potent Mcl-1 inhibitors in future. Thus, the present study was an attempt to speed up the anticancer drug discovery of indole-based Mcl-1 inhibitors.
Interested yet? Keep reading other articles of 5932-27-4, you can contact me at any time and look forward to more communication. COA of Formula: C6H8N2O2.
Reference:
Pyrazole – Wikipedia,
,Pyrazoles – an overview | ScienceDirect Topics